What is the mechanism of action and therapeutic use of Jadcady (nerandomilast)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Jadcady: Topical Pain Relief for Musculoskeletal Conditions

Jadcady is a topical medicated oil used for temporary relief of minor muscle and joint aches and pains, applied directly to the affected area 1-2 times daily. 1

What It Does

Jadcady provides temporary relief of minor aches and pains associated with:

  • Simple backache
  • Muscle strains and sprains
  • Bruises
  • Arthritis 1

How to Use It

Application Instructions:

  • Apply 3-4 drops of the medicated oil to the affected area 1-2 times daily
  • After application, a warm pad may be placed on the area for 10 minutes, followed by massage
  • Suitable for adults and children ≥3 years of age
  • Children under 3 years require physician consultation 1

Important Safety Information

This is for external use only and should not be used on:

  • Open wounds
  • Irritated or damaged skin 1

Key Precautions:

  • Avoid contact with eyes or mucous membranes
  • Do not bandage tightly
  • Keep out of reach of children 1

Stop use and consult a physician if:

  • Condition worsens
  • Symptoms persist beyond 7 days
  • Symptoms resolve but recur within a few days
  • Excessive skin irritation develops
  • Gastrointestinal symptoms (nausea, vomiting, abdominal discomfort, diarrhea) or skin rash occurs 1

Critical Distinction

Note: This topical product (Jadcady) is completely different from the oral medication nerandomilast (marketed as Jascayd®), which is a phosphodiesterase 4B inhibitor approved for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis 2, 3, 4. The similar naming could lead to confusion, but these are entirely separate medications with different routes of administration, mechanisms of action, and therapeutic indications.

References

Research

Precision Modulation of the PDE4 Pathway: The Emerging Role of Nerandomilast in Pulmonary Fibrosis.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.